← Eichor
Study identifier: NCT03710902 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Empowerment and Mobile Technology in the Control of Cardiovascular Risk Factors in Patients With Ischemic Stroke

Condition: Ischemic Stroke · Transient Ischemic Attack · Atrial Fibrillation  ·  Sponsor: Jukka Putaala

PhaseNA
Planned participants405
Who can joinAll sexes, 40 Years to no upper limit
Healthy volunteersNo

About this study

The CARDIOSTROKE is a randomized trial comparing mobile-device assisted control of hypertension together with screening of occult atrial fibrillation to standard care in patients with recent ischemic stroke or transient ischemic attack.

This description comes directly from the study's public registry record.

Talk to the study team

Tuomas Lumikari, MD  ·  +35894711  ·  tuomas.lumikari@helsinki.fi

Anu Eräkanto  ·  anu.erakanto@hus.fi

Always discuss trial participation with your own doctor first.

Locations (4)

Kanta-Häme Central HospitalHämeenlinna, FinlandRecruiting
Helsinki University HospitalHelsinki, FinlandRecruiting
Hyvinkää HospitalHyvinkää, FinlandRecruiting
Päijät-Häme Central HospitalLahti, FinlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03710902